215 related articles for article (PubMed ID: 22902288)
1. The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.
Martyn-St James M; Glanville J; McCool R; Duffy S; Cooper J; Hugel P; Lane PW
Seizure; 2012 Nov; 21(9):665-78. PubMed ID: 22902288
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
[TBL] [Abstract][Full Text] [Related]
4. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.
Gao L; Xia L; Zhao FL; Li SC
Epilepsy Res; 2013 Jan; 103(1):31-44. PubMed ID: 22776828
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
Lim KS; Lotay N; White R; Kwan P
Epilepsy Behav; 2016 Aug; 61():224-230. PubMed ID: 27376872
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
Tompson DJ; Crean CS; Reeve R; Berry NS
Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
[TBL] [Abstract][Full Text] [Related]
9. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
Porter RJ; Burdette DE; Gil-Nagel A; Hall ST; White R; Shaikh S; DeRossett SE
Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
[TBL] [Abstract][Full Text] [Related]
10. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.
Porter RJ; Partiot A; Sachdeo R; Nohria V; Alves WM;
Neurology; 2007 Apr; 68(15):1197-204. PubMed ID: 17420403
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo F; Bragazzi NL; Nardone R; Trinka E
Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
[TBL] [Abstract][Full Text] [Related]
12. Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
Craig D; Rice S; Paton F; Fox D; Woolacott N
Pharmacoeconomics; 2013 Feb; 31(2):101-10. PubMed ID: 23341194
[TBL] [Abstract][Full Text] [Related]
13. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
Groth A; Wilke T; Borghs S; Gille P; Joeres L
Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
[No Abstract] [Full Text] [Related]
14. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
Biton V; Gil-Nagel A; Brodie MJ; Derossett SE; Nohria V
Epilepsy Res; 2013 Nov; 107(1-2):138-45. PubMed ID: 24094693
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis.
Khan N; Shah D; Tongbram V; Verdian L; Hawkins N
Curr Med Res Opin; 2013 Aug; 29(8):1001-13. PubMed ID: 23659562
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton V; Rogin JB; Krauss G; Abou-Khalil B; Rocha JF; Moreira J; Gama H; Trinka E; Elger CE; Cheng H; Grinnell T; Blum D;
Epilepsy Behav; 2017 Jul; 72():127-134. PubMed ID: 28575761
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
Nass RD; Kurth C; Kull A; Graf W; Kasper B; Hamer HM; Strzelczyk A; Elger CE; Steinhoff BJ; Surges R; Rosenow F
Epilepsy Behav; 2016 Mar; 56():54-8. PubMed ID: 26828693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]